Published in Eur Neuropsychopharmacol on October 01, 2011
Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci (2013) 1.16
Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology (2013) 1.03
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr (2011) 0.93
A Role for Oxytocin in the Etiology and Treatment of Schizophrenia. Front Endocrinol (Lausanne) (2015) 0.79
Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β-Arrestin-Independent Internalisation. J Neuroendocrinol (2016) 0.77
Oxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric Traits. Front Neurosci (2016) 0.76
Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs. Behav Brain Res (2014) 0.76
The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice. PLoS One (2015) 0.75
Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology (2015) 0.75
Effects of oxytocin on background anxiety in rats with high or low baseline startle. Psychopharmacology (Berl) (2016) 0.75
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52
The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron (2010) 3.56
Sensorimotor gating deficits in adults with autism. Biol Psychiatry (2006) 2.31
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry (2011) 2.25
The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry (2010) 1.99
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry (1994) 1.90
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry (2010) 1.81
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res (2010) 1.52
Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology (2005) 1.33
Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res (2007) 1.32
Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology (Berl) (1999) 1.14
Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr Top Behav Neurosci (2010) 1.12
Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci (2000) 1.05
Blood-brain barrier and peptides. J Cereb Blood Flow Metab (1985) 1.04
Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol Psychiatry (2008) 1.01
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology (1985) 1.00
A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav (2007) 0.97
Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci (1984) 0.93
Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci (2005) 0.91
Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field. J Physiol Pharmacol (2009) 0.89
The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neurosignals (2010) 0.87
Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology (Berl) (2010) 0.86
Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists. Neuro Endocrinol Lett (2009) 0.85
Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol (1998) 0.83
On the blood-brain barrier to peptides: effects of immobilization stress on regional blood supply and accumulation of labelled peptides in the rat brain. Endocr Regul (1992) 0.82
Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats. Behav Neurosci (2011) 0.82
Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG (2010) 0.78
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet (2011) 1.23
Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology (2010) 1.17
Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Neuropsychopharmacology (2004) 1.11
The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav Brain Res (2007) 1.06
The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog. Neuropsychopharmacology (2009) 1.02
The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance. Psychopharmacology (Berl) (2008) 1.01
A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist. Neuropsychopharmacology (2002) 1.00
Methamphetamine-induced neural and cognitive changes in rodents. Addiction (2007) 0.99
The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature. Neuropharmacology (2009) 0.93
Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats. Neurosci Lett (2003) 0.92
Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology (Berl) (2012) 0.84
Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: a (1) H MR spectroscopy study. Addict Biol (2013) 0.83
Rodent models of adaptive decision making. Methods Mol Biol (2012) 0.83
Evidence for association of bipolar disorder to haplotypes in the 22q12.3 region near the genes stargazin, IFT27 and parvalbumin. Am J Med Genet B Neuropsychiatr Genet (2012) 0.83
Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats. Behav Neurosci (2011) 0.82
Promise and pitfalls of animal models of schizophrenia. Curr Psychiatry Rep (2010) 0.82
Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1. Transl Psychiatry (2012) 0.78
Effects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activity. Behav Brain Res (2010) 0.77